ENO3 and hepatocellular carcinoma: For example, ENO3 is up-regulated in STK11 mutant pulmonary carcinoma (Park et al., 2019) and colorectal carcinoma (Xiaohang et al., 2020; Zhu et al., 2021), while down-regulated in pancreatic cancer (Tan et al., 2020) and hepatocellular carcinomas (Liu et al., 2019).